Related Experiment Video
Updated: Apr 15, 2026

08:23
Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Published on: September 25, 2018
14.2K
Development of a gLCR-based KRAS mutation detection approach and its comparison with other screening methods
1Division of Molecular Pathology, Department of Pathology, Katharinen Hospital Stuttgart, Kriegsbergstr. 60, 70374, Stuttgart, Germany, s.jenner@klinikum-stuttgart.de.
Summary
A novel gapped ligase chain reaction (gLCR) technique accurately detects low-level KRAS mutations in colorectal cancer tissues. This highly sensitive method confirms doubtful results from other screening techniques with high reproducibility.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Colorectal cancer (CRC) diagnosis relies on accurate mutation detection.
- KRAS mutations in codons 12 and 13 are critical biomarkers in CRC.
- Existing screening techniques may lack sensitivity for low-level mutations.
Purpose of the Study:
- To develop and validate a gapped ligase chain reaction (gLCR) technique.
- To assess gLCR's sensitivity and specificity for detecting KRAS mutations.
- To evaluate gLCR for confirming results from less sensitive screening methods.
Main Methods:
- Development of a monoplex gLCR assay.
- Testing on clinical formalin-fixed, paraffin-embedded (FFPE) colorectal cancer tissues.
- Comparison with standard mutation screening techniques.
Main Results:
- The gLCR technique demonstrated high sensitivity, detecting one mutated allele among at least one million wild-type alleles (0.0001%).
- It showed high reproducibility with low signal amplitude variance.
- gLCR proved effective in confirming doubtful KRAS mutation screening results.
Conclusions:
- The gLCR technique is a powerful tool for detecting low-level KRAS codon 12/13 mutations in FFPE tissues.
- Its high sensitivity and reproducibility make it ideal for confirming ambiguous screening results.
- The technique is cost-effective, requires minimal handling time, and is adaptable for other mutation hotspots.

